Rational therapy of bacterial vaginosis

Purpose of the study was to evaluate the efficiency and duration of clindamycin (Banbact®) therapeutic effect  in the treatment of bacterial vaginosis in women of reproductive age. Materials and methods. The study included 47 patients with bacterial vaginosis aged 20–37 years. Vaginal dysbiosis was...

Full description

Bibliographic Details
Main Authors: T. G. Romanenko, G. M. Zhaloba, О. М. Sulimenko
Format: Article
Language:English
Published: Publishing House TRILIST 2020-11-01
Series:Репродуктивная эндокринология
Subjects:
Online Access:http://reproduct-endo.com/article/view/218440
_version_ 1819027404217122816
author T. G. Romanenko
G. M. Zhaloba
О. М. Sulimenko
author_facet T. G. Romanenko
G. M. Zhaloba
О. М. Sulimenko
author_sort T. G. Romanenko
collection DOAJ
description Purpose of the study was to evaluate the efficiency and duration of clindamycin (Banbact®) therapeutic effect  in the treatment of bacterial vaginosis in women of reproductive age. Materials and methods. The study included 47 patients with bacterial vaginosis aged 20–37 years. Vaginal dysbiosis was established on the basis of symptoms indicated by women themselves, results of gynecological examination that was consisting of examination, measurement of vaginal pH based on the Amsels criteria, evaluation of vaginal microbiocenosis by polymerase chain reaction. Treatment was performed with Banbact® – vaginal suppositories clindamycin 100 mg 1 day before bedtime for 6 days. Treatment criteria were no subjective complaints, normal discharge in quantity, odor and consistency; decrease of leukocytes number in smears, secretions pH <4.5, negative amine test, absence of key cells in smears, decrease of pathogenic microflora and increase of lactoflora. Results. On the 14th day after treatment all patients noted a significant improvement in the general condition and decrease in vaginal discharge. Clue cells were detected in only in 1 patient after treatment, accounting for 2.13% of cases. The pH of discharge in all patients was significantly decreased by the 14th day after treatment. There was a clear tendency to reduce the number of G. vaginalis, staphylococci, Mobiluncus spp., A. vaginae, Streptococcus spp. and Staphylococcus spp. and appearance of lactobacilli during treatment. Results of the study show clinical effectiveness of bacterial vaginosis therapy in 93.61% of patients, and laboratory one in 90.12%. Positive effect of therapy persisted for 1 month. Conclusion. Results of the study showed that is clindamycin (Banbact®) is an effective and optimal agent for local therapy of bacterial vaginosis in women of reproductive age. Action spectrum of the antimicrobial and antiseptic drug allows eliminating pathogenic microflora within a short period. There is no systemic effect this drug on the body.
first_indexed 2024-12-21T05:41:56Z
format Article
id doaj.art-a998c38464eb4df2976cc1e73f1d5c77
institution Directory Open Access Journal
issn 2309-4117
2411-1295
language English
last_indexed 2024-12-21T05:41:56Z
publishDate 2020-11-01
publisher Publishing House TRILIST
record_format Article
series Репродуктивная эндокринология
spelling doaj.art-a998c38464eb4df2976cc1e73f1d5c772022-12-21T19:14:14ZengPublishing House TRILISTРепродуктивная эндокринология2309-41172411-12952020-11-01055586110.18370/2309-4117.2020.55.58-61218440Rational therapy of bacterial vaginosisT. G. Romanenko0G. M. Zhaloba1О. М. Sulimenko2P.L. Shupyk NMAPE of the MoH of Ukraine, KyivP.L. Shupyk NMAPE of the MoH of Ukraine, KyivP.L. Shupyk NMAPE of the MoH of Ukraine, KyivPurpose of the study was to evaluate the efficiency and duration of clindamycin (Banbact®) therapeutic effect  in the treatment of bacterial vaginosis in women of reproductive age. Materials and methods. The study included 47 patients with bacterial vaginosis aged 20–37 years. Vaginal dysbiosis was established on the basis of symptoms indicated by women themselves, results of gynecological examination that was consisting of examination, measurement of vaginal pH based on the Amsels criteria, evaluation of vaginal microbiocenosis by polymerase chain reaction. Treatment was performed with Banbact® – vaginal suppositories clindamycin 100 mg 1 day before bedtime for 6 days. Treatment criteria were no subjective complaints, normal discharge in quantity, odor and consistency; decrease of leukocytes number in smears, secretions pH <4.5, negative amine test, absence of key cells in smears, decrease of pathogenic microflora and increase of lactoflora. Results. On the 14th day after treatment all patients noted a significant improvement in the general condition and decrease in vaginal discharge. Clue cells were detected in only in 1 patient after treatment, accounting for 2.13% of cases. The pH of discharge in all patients was significantly decreased by the 14th day after treatment. There was a clear tendency to reduce the number of G. vaginalis, staphylococci, Mobiluncus spp., A. vaginae, Streptococcus spp. and Staphylococcus spp. and appearance of lactobacilli during treatment. Results of the study show clinical effectiveness of bacterial vaginosis therapy in 93.61% of patients, and laboratory one in 90.12%. Positive effect of therapy persisted for 1 month. Conclusion. Results of the study showed that is clindamycin (Banbact®) is an effective and optimal agent for local therapy of bacterial vaginosis in women of reproductive age. Action spectrum of the antimicrobial and antiseptic drug allows eliminating pathogenic microflora within a short period. There is no systemic effect this drug on the body.http://reproduct-endo.com/article/view/218440bacterial vaginosisantimicrobial agentsclindamycin
spellingShingle T. G. Romanenko
G. M. Zhaloba
О. М. Sulimenko
Rational therapy of bacterial vaginosis
Репродуктивная эндокринология
bacterial vaginosis
antimicrobial agents
clindamycin
title Rational therapy of bacterial vaginosis
title_full Rational therapy of bacterial vaginosis
title_fullStr Rational therapy of bacterial vaginosis
title_full_unstemmed Rational therapy of bacterial vaginosis
title_short Rational therapy of bacterial vaginosis
title_sort rational therapy of bacterial vaginosis
topic bacterial vaginosis
antimicrobial agents
clindamycin
url http://reproduct-endo.com/article/view/218440
work_keys_str_mv AT tgromanenko rationaltherapyofbacterialvaginosis
AT gmzhaloba rationaltherapyofbacterialvaginosis
AT omsulimenko rationaltherapyofbacterialvaginosis